(Q53212463)
Statements
First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies. (English)
Kyu-pyo Kim
Seong Joon Park
Jeong-Eun Kim
Yong Sang Hong
Jae-Lyun Lee
Hyunju Cha
Sool-Ki Kwon
Seonggu Ro
JoongMyung Cho
17 June 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference